Teucrium Commodity Trust

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Item 8.01. Other Events

On November 4, 2025, Teucrium Trading. LLC, the sponsor of Teucrium Commodity Trust (the “Registrant”) issued a press release announcing a one-for-five reverse split of the shares of Teucrium Wheat Fund (the “Fund”). The reverse share split will take place at 5:00 p.m. Eastern Standard Time on November 24, 2025 and will be effective on November 25, 2025. The reverse split will increase the price per share of the Fund with a proportionate decrease in the number of shares outstanding. As a result of the reverse split, every five pre-split shares will result in the receipt of one post-split share, which will be priced five times higher than the net asset value of a pre-split share. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this Item 8.01.

Item 9.01. Financial Statements and Exhibits